{"data":{"Year":[2010,2011,2012,2013,2014,2015,2016,2017,2018,2019,2020,2021,2022,2013,2014,2015,2016,2017,2018,2019,2020,2021,2022,2010,2011,2012,2013,2014,2015,2016,2017,2018,2019,2020,2021,2022,2021,2022],"Series":["Proportion of the target population who received 3 doses of diphtheria-tetanus-pertussis (DTP3) vaccine (%)","Proportion of the target population who received 3 doses of diphtheria-tetanus-pertussis (DTP3) vaccine (%)","Proportion of the target population who received 3 doses of diphtheria-tetanus-pertussis (DTP3) vaccine (%)","Proportion of the target population who received 3 doses of diphtheria-tetanus-pertussis (DTP3) vaccine (%)","Proportion of the target population who received 3 doses of diphtheria-tetanus-pertussis (DTP3) vaccine (%)","Proportion of the target population who received 3 doses of diphtheria-tetanus-pertussis (DTP3) vaccine (%)","Proportion of the target population who received 3 doses of diphtheria-tetanus-pertussis (DTP3) vaccine (%)","Proportion of the target population who received 3 doses of diphtheria-tetanus-pertussis (DTP3) vaccine (%)","Proportion of the target population who received 3 doses of diphtheria-tetanus-pertussis (DTP3) vaccine (%)","Proportion of the target population who received 3 doses of diphtheria-tetanus-pertussis (DTP3) vaccine (%)","Proportion of the target population who received 3 doses of diphtheria-tetanus-pertussis (DTP3) vaccine (%)","Proportion of the target population who received 3 doses of diphtheria-tetanus-pertussis (DTP3) vaccine (%)","Proportion of the target population who received 3 doses of diphtheria-tetanus-pertussis (DTP3) vaccine (%)","Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%)","Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%)","Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%)","Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%)","Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%)","Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%)","Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%)","Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%)","Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%)","Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%)","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)"],"Value":[76,96,99,99,99,97,97,98,97,98,98,99,98,29,91,87,82,78,80,82,82,96,76,85,85,91,88,94,91,86,83,95,95,99,93,95,99,99]},"edges":[]}